← Back to Screener
Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)
Price$0.45
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-76.18%
Price vs S&P 500 (4W)-34.12%
VGM Score12.79
Market Capitalization$2.66M
All Metrics
Book Value / Share (Quarterly)$0.60
P/TBV (Annual)1.06x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.25
Price vs S&P 500 (YTD)-82.94%
EPS (TTM)$-5.71
10-Day Avg Trading Volume3.18M
EPS Excl Extra (TTM)$-5.71
EPS (Annual)$-7.16
ROI (Annual)-578.78%
Cash / Share (Quarterly)$0.20
ROA (Last FY)-364.33%
EBITD / Share (TTM)$-3.55
ROE (5Y Avg)-348.67%
Cash Flow / Share (Annual)$-45.80
P/B Ratio0.79x
P/B Ratio (Quarterly)1.13x
Net Income / Employee (Annual)$-5,860,800
Net Interest Coverage (TTM)-80.32x
ROA (TTM)-138.15%
EPS Incl Extra (Annual)$-7.16
Current Ratio (Annual)1.44x
Quick Ratio (Quarterly)0.13x
3-Month Avg Trading Volume1.04M
52-Week Price Return-89.63%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.45
52-Week High$6.19
EPS Excl Extra (Annual)$-7.16
CapEx CAGR (5Y)214.09%
26-Week Price Return-68.25%
Quick Ratio (Annual)1.25x
13-Week Price Return-47.73%
Total Debt / Equity (Annual)1.23x
Current Ratio (Quarterly)0.30x
Enterprise Value$1.57M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$12.00
3-Month Return Std Dev142.98%
Net Income / Employee (TTM)$-5,410,600
ROE (Last FY)-1288.00%
Net Interest Coverage (Annual)-80.32x
EPS Basic Excl Extra (Annual)$-7.16
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.71
Receivables Turnover (Annual)0.00x
ROI (TTM)-377.57%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.56
Price vs S&P 500 (52W)-114.00%
Year-to-Date Return-74.78%
5-Day Price Return-14.82%
EPS Normalized (Annual)$-7.16
ROA (5Y Avg)-167.42%
Month-to-Date Return-13.52%
Cash Flow / Share (TTM)$-0.36
EBITD / Share (Annual)$-6.89
LT Debt / Equity (Annual)0.03x
ROI (5Y Avg)-201.22%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-5.71
P/TBV (Quarterly)1.18x
P/B Ratio (Annual)4.43x
Book Value / Share (Annual)$4.44
Price vs S&P 500 (13W)-55.98%
Beta1.19x
Revenue / Share (TTM)$0.00
ROE (TTM)-408.33%
52-Week Low$0.38
mGradeF
vgmGradeF
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SHPHShuttle Pharmaceuticals Holdings, Inc. Common Stock | — | — | F | $0.45 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Shuttle Pharmaceuticals is a clinical-stage biopharmaceutical company developing proprietary technologies to enhance the efficacy of cancer treatments across multiple modalities, including radiation therapy, chemotherapy, and immunotherapy. The company's pipeline addresses limitations of current standard-of-care treatments while aiming to deliver safer, more reliable, and more accessible therapeutic options.